See also this year's filing and all EDGAR filings for this company.
PDF Report 0001442836_2019_Mersana_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001442836, Mersana Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 74,305,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 2,694,000 |
| 3 | remainder_Assets | 1,503,000 |
| 4 | LiabilitiesCurrent | 69,425,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 282,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 16,334,000 |
| 9 | ResearchAndDevelopmentExpense | 59,915,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 10,594,000 |
| 12 | remainder_NetIncome | 1,398,000 |
| 13 | remainder_ComprehensiveNetIncome | 141,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 78,502,000 |
| 1 | Liabilities | 69,707,000 |
| 2 | Expenses | 76,249,000 |
| 3 | Revenues | 10,594,000 |
| 4 | StockholdersEquity | 8,795,000 |
| 5 | NetIncome | -64,257,000 |
| 6 | ComprehensiveNetIncome | -64,186,500 |
| 7 | BaseVar | 118,295,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -0.607 |
| 9 | EconomicCapitalRatio | 1.37 |
Edgar->Model Mapping
Feature Distribution
Change over Time
